bioAffinity Technologies announces the grant of US patents protecting novel compounds for the specific delivery of cancer treatment

SAN ANTONIO–(BUSINESS WIRE)–bioAffinity Technologies, Inc. (NASDAQ: BIAF; BIAFW) announced today that the US Patent and Trademark Office (USPTO) has granted a Notice of Allowance for a patent application entitled “Porphyrin compounds and compositions useful for the treatment of cancer” for the targeted delivery of new cancer drugs. A Notice of Allowance is issued after the …

bioAffinity Technologies announces the grant of US patents protecting novel compounds for the specific delivery of cancer treatment Read More »